Efficacy and Safety of Empagliflozin on Nonalcoholic Fatty Liver Disease: A Systematic Review and Meta-Analysis

OBJECTIVE: Clinical trials have recently shown a connection between nonalcoholic fatty liver disease (NAFLD) and empagliflozin. This paper aimed at comprehensively assessing the effectiveness and security of empagliflozin in NAFLD patients. METHODS: PubMed, Embase, Web of Science, Cochrane Library,...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yuyuan, Liu, Xiaobo, Zhang, Huazhu, Wang, Xuechang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Endocrinology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908261/
https://www.ncbi.nlm.nih.gov/pubmed/35282455
http://dx.doi.org/10.3389/fendo.2022.836455

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8908261/
https://www.ncbi.nlm.nih.gov/pubmed/35282455
http://dx.doi.org/10.3389/fendo.2022.836455

Ejemplares similares